Samrucin 50mg Injection
Marketer
Cellcys Labs Private Limited
Salt Composition
Doxorubicin (Plain) (50mg)
Overview Samrucin 50mg Injection
Oncaspar 50mg Injection treats various blood, breast, lung, ovarian, and soft tissue cancers. Administered intravenously by a healthcare professional, it may be used alone or in combination chemotherapy. Dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe complications. Therapeutic effects might not be immediately apparent; continue treatment unless instructed otherwise. This medication can reduce contraceptive efficacy; reliable contraception is recommended for both men and women throughout treatment. Common side effects include nausea, vomiting, allergic reactions, mucositis, and alopecia. Report any concerning side effects to your doctor; management strategies are available. Samrucin can decrease blood cell counts, increasing infection risk, potentially life-threatening. Regular blood tests monitoring blood cell levels, renal, hepatic, and cardiac function are essential. Inform your doctor of any pre-existing severe liver or heart conditions, pregnancy, breastfeeding, or other medications you're taking, as interactions may impact efficacy or treatment.
Uses of Samrucin 50mg Injection
Malignant neoplasm
Major Benefits of Samrucin 50mg Injection:
Administering this medication will be handled by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Samrucin 50mg Injection:
- Vomiting
- Allergic reaction
- Nausea
- Mouth sore
- Hair loss
- Stomach pain
- Eye disorder
- Increased thirst
- Arrhythmia (irregular heartbeats)
- Nail disorder
How to use Samrucin 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Samrucin 50mg Injection works:
Samrucin 50mg Injection is an anticancer agent that inhibits topoisomerase II, an enzyme crucial for cancer cell DNA replication. Its mechanism of action also involves the generation of cytotoxic free radicals, leading to DNA damage. This dual action impedes cancer cell proliferation, ultimately resulting in cell death.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Samrucin 50mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Samrucin 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. Exceptions may exist in critical medical emergencies where the potential benefits outweigh the known hazards, at the physician's sole discretion. Physician consultation is essential.
Breast feedingUNSAFE
Administering Samrucin 50mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The 50mg Samrucin Injection can induce adverse reactions that may impair driving ability. Since nausea and vomiting are common side effects of this injection, operating a vehicle is not recommended.
KidneySAFE IF PRESCRIBED
Samrucin 50mg Injection poses no known safety risk for individuals with kidney impairment; no dosage alteration is necessary. Nevertheless, disclosure of any kidney condition to your physician is advisable.
LiverCAUTION
Patients with hepatic impairment should use Samrucin 50mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Samrucin 50mg Injection :
NA
Facts to Know About Samrucin 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Cytotoxic alkaloids |
3,018 People bought this recently